I've decided to share some of my notes on earnings results of stocks that I either own or are watching. These notes are typically in bullet format and highlight some of the important points. I hope that these may be of help to other shareholders or investors interested in the stock. Today notes are on CVS Health which is in the top 10% cheapest stocks according to my … [Read more...]
The First Real Evidence Of A Bubble
Today I’d like to talk about what I think is the first real evidence of a bubble forming in the global markets. We’ve been hearing this since at least 2014. And while I too convinced myself that 2016 was it, which result in a failed attempt to time the market, I believe the first real signs of a bubble have just appeared. But that too doesn’t mean it will burst right away or … [Read more...]
3 Interesting Ideas
Below is a brief discussion of the three investment ideas I presented at the Cyprus Value Investor Conference. Office Depot (ODP) is a cost savings story where reductions have resulted in significant improvements in operating margins over the last few years. Sales growth though remains a headache and last quarter same-store sales were -6% (a 3-year low). Management … [Read more...]
A $1 Million Bet That Target Is Cheap
Summary Insiders have bought over $1 million worth of Target. Unlike the majority of the market, Target trades at a discount to its value. Stock price appears to have stabilized. Potential earnings beats or any improvement could see the stock much higher. First quarter results provided a hint that Target (NYSE:TGT) may not be doing as poorly as the wider market … [Read more...]
Should Investors Sell Apple?
Summary What is the value of Apple stock? If the stock has exceeded its value then shouldn't even investors be selling? The article applies 6 different valuation methods to answer that question. If the stock is no longer cheap then what are the reasons for holding on to the stock? As a value investor and owner of Apple (NASDAQ:AAPL) stock, I am always concerned … [Read more...]
Bed Bath & Beyond Products Are Still Cheaper Than Amazon
Summary The company has had a very long and strong history of growth, profitability and operating returns. Margins continue to be the major question mark; however, the peak rate of decline may be behind us. The stock appears to have overshot to the downside and trades at a significant discount to valuation. Online sales continue to expand at a 20%+ rate. The … [Read more...]
GNC Needs Vitamin Shoppe To Close The KKR Deal
Summary Points: A private equity acquisition of both GNC and Vitamin Shoppe makes more sense than buying GNC alone. The deal will leave private equity with more upside and result in a premium that GNC/VSI investors will accept. The deterioration in GNC financials increases the difficult of getting the deal done. VSI is an alternative way to get exposure to any … [Read more...]
